FDA approves new silicone gel-filled breast implant

February 21, 2013
FDA approves new silicone gel-filled breast implant
The Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant has been approved by the U.S. Food and Drug Administration for breast augmentation in women aged 22 years or older and for reconstruction in women of all ages.

(HealthDay)—The Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant has been approved by the U.S. Food and Drug Administration for breast augmentation in women aged 22 years or older and for reconstruction in women of all ages.

The FDA approval was based on data from 941 women followed for seven years. Complications included capsular contracture, re-operation, implant removal, asymmetry, and infection, most of which have been identified in previous breast implant studies. In addition, gel fractures or fissures were observed in the gel of some Natrelle 410 implants.

The FDA has required that the manufacturer, Allergan, conduct post-approval studies, including a five-year follow-up involving about 3,500 women who received the implants as part of the company's access study; a 10-year follow-up of more than 2,000 women to identify long-term complications; and five case-control studies to examine the correlation of the implants with . They have also required an assessment of women's perceptions of the patient labeling and analysis of implants removed from patients and returned to the manufacturer.

The implant is manufactured by Allergan Inc., based in Irvine, Calif.

Explore further: FDA clears 3rd silicone-gel breast implant for US

More information: More Information

Related Stories

FDA clears 3rd silicone-gel breast implant for US

March 9, 2012
(AP) -- The Food and Drug Administration has approved a new silicone-gel breast implant from Sientra, making it the third company to market the controversial products in the U.S.

Consumer group questions review of breast implants

January 5, 2012
(AP) -- Consumer safety advocates are questioning the Food and Drug Administration about seemingly incomplete and erroneous data used to affirm the safety of silicone breast implants last year.

7,000 more women in Britain received suspect implants

March 15, 2012
Around 7,000 more women than first thought in Britain have received potentially faulty PIP breast implants, the government said on Thursday.

Australia: No higher risk from French implants

January 5, 2012
(AP) -- Australian health officials said they have found no evidence that potentially faulty French-made breast implants are at an increased risk of rupture in Australian women.

Recommended for you

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

Best of Last Year – The top Medical Xpress articles of 2016

December 23, 2016
(Medical Xpress)—It was a big year for research involving overall health issues, starting with a team led by researchers at the UNC School of Medicine and the National Institutes of Health who unearthed more evidence that ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.